TAVR (Transcatheter Aortic Valve Replacement) Success Rate in Hyderabad
Access high-quality treatment through JCI & NABH-accredited hospitals, renowned specialists, and end-to-end medical travel support designed around your healing journey.
Plan My Journey
Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway
Cost calculator
I know my treatment - show me cost from 3 hospitals
5K+ International Patients Treated
40+ Source Countries Served
500+ Accredited Partner Hospitals
98% Patient Satisfaction
80% Average Savings vs USA
10K+ Doctors
NABH, JCI Accredited Hospitals
Free Treatment Plan
Free Consultation with Doctor
5+ Destinations Covered
Written by DivinHeal Editorial Contributor, DivinHeal Medical Team, Healthcare Advisory Team Published on: February 19, 2026
About
TAVR Success Rate in Hyderabad: Outcomes and Survival
Understanding the TAVR (Transcatheter Aortic Valve Replacement) success rate in Hyderabad is vital for individuals exploring cardiac valve replacement. This success is influenced by factors like patient health, the severity of aortic stenosis, and specific procedural details. Hyderabad's advanced healthcare ecosystem provides robust facilities, with TAVR outcomes continuously reviewed to inform patient decisions effectively.
The TAVR (Transcatheter Aortic Valve Replacement) survival rate in Hyderabad is meticulously tracked, drawing comparisons with national and global benchmarks. Aggregated clinical data from regional institutions contribute to this evaluation, revealing variations based on patient comorbidities, age, and procedural specifics. This systematic approach ensures a comprehensive, data-driven understanding of treatment efficacy.
Defining TAVR Success and Recovery
For TAVR (Transcatheter Aortic Valve Replacement), "success" typically encompasses several key outcomes. This includes successful valve implantation, significant improvement in heart function, symptom reduction, and an improved quality of life. The long-term TAVR (Transcatheter Aortic Valve Replacement) recovery rate in Hyderabad is also a critical indicator, aiming for sustained functional improvement and patient well-being.
TAVR Success Rate Breakdown by Approach
Success rates for TAVR procedures vary significantly, depending on the patient's individual health profile, the specific procedural approach, and overall cardiovascular condition.
| TAVR Approach / Patient Profile | Typical Use Case | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| Standard Risk Patients (Transfemoral) | Minimally invasive approach for suitable anatomies | 95%–98% | Successful valve deployment, immediate hemodynamic improvement, symptom relief |
| Intermediate/High-Risk Patients | Those with significant comorbidities via transfemoral or alternative access | 90%–96% | Effective valve replacement, improved cardiac function, reduction in symptoms |
| Complex Cases (e.g., Valve-in-Valve) | Replacement of failed surgical bioprosthetic valves or challenging anatomies | 88%–94% | Restored valve function, avoidance of open-heart surgery, long-term stability |
Age and Stage-Wise TAVR Survival Rates in Hyderabad
The stage wise TAVR (Transcatheter Aortic Valve Replacement) survival rate in Hyderabad varies based on the severity of aortic stenosis and overall patient health at the time of the procedure. Similarly, the TAVR (Transcatheter Aortic Valve Replacement) survival rate by age in Hyderabad aligns closely with global observations, where outcomes are generally more favorable in younger, healthier patient cohorts, reflecting comprehensive risk assessment. Leading centers across Hyderabad follow evidence-based protocols, comparable to international standards in patient selection and post-procedural care.
| Age Group / Patient Category | Associated Risk Factors | Survival Rate Range (%) |
|---|---|---|
| Younger Patients (e.g., <75 years) | Fewer comorbidities, better general health | 92%–97% |
| Elderly Patients (e.g., >75 years) | Increased likelihood of comorbidities, frailty | 88%–93% |
| Patients with Severe Comorbidities | Advanced kidney disease, severe lung disease, previous stroke | 80%–88% |
Hyderabad TAVR Outcomes vs. Global Standards
Success rates for TAVR (Transcatheter Aortic Valve Replacement) in Hyderabad are increasingly comparable with international standards. This alignment is observed when similar protocols, advanced technology, and rigorous patient selection criteria are applied across leading cardiac centers in the region.
| Region / Country | TAVR Survival Rate Range (%) |
|---|---|
| Hyderabad, India | 90%–96% |
| United States | 91%–97% |
| Germany | 90%–96% |
| United Kingdom | 89%–95% |
| Canada | 90%–96% |
| Australia | 89%–95% |
| Singapore | 90%–96% |
These success rates are indicative and reflect aggregated clinical outcomes, not a guarantee for individual cases. Actual results can vary significantly based on specific patient health, co-existing conditions, and the chosen treatment approach.
Key Factors Influencing TAVR Success Rate
- Severity of Aortic Stenosis: The extent of valve calcification and obstruction.
- Patient Age and Frailty: Advanced age and overall physical condition.
- Co-existing Medical Conditions: Presence of other heart diseases, kidney failure, or lung issues.
- Ejection Fraction and Heart Function: The strength of the heart's pumping ability.
- Procedural Expertise and Experience: The skill of the medical team performing TAVR.
- Post-Procedural Care and Rehabilitation: Adherence to recovery protocols.
- Anatomical Suitability: Features of the aorta and valve relevant to device fit.
Data Sources & Methodology for Outcome Analysis
- National and regional cardiac registries provide comprehensive procedural data.
- Peer-reviewed medical literature and outcomes from clinical trials.
- Aggregated outcome data compiled from multiple leading cardiac centers.
- Internal institutional reviews and quality improvement programs contribute to insights.
Making Informed TAVR Decisions
Understanding TAVR outcomes with factual data empowers patients. Focus on evidence-based discussions with healthcare providers to make confident and personalized decisions for your cardiac health journey.
Hospitals
NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.
Artemis Hospital
Sector 51, Gurugram, Haryana, India
Lokmanya Hospitals
Not Specified
White Lotus Hospital
766, SFS 3145, SFS Road, 7th Sector, HSR Layout, Bengaluru, Karnataka 560102, India
Institute of Brain and Spine (IBS Hospital)
Not Specified
Meet Our Medical Specialists
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
How DivinHeal Helps
We simplify your medical journey by providing comprehensive support and access to world-class healthcare.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Accredited Hospital Network
Access to JCI & NABH certified healthcare facilities.
Complete Travel Coordination
Hassle-free visa, stay, and local transport assistance.
24/7 Personal Care
Dedicated patient advisors supporting you at every step.
Journey Guidance
Full guidance from start to end of the patient treatment journey.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Everything you
need to know today
Browse through these common inquiries to better understand our patient-focused medical platform.
Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.
Yes, we provide secure online consultations with experienced specialists.
Our care coordinators help match you with the most suitable specialist.
Absolutely. Your medical information is protected according to healthcare privacy standards.
Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.
JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.
Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.
Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.
DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.
You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.
Still have more questions?
Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.